Cargando...
Randomized, multi-center trial of argatroban with recombinant tissue plasminogen activator for acute stroke (ARTSS-2)
BACKGROUND AND PURPOSE: We conducted a randomized exploratory study to assess safety and the probability of a favorable outcome with adjunctive argatroban, a direct thrombin-inhibitor, administered to rt-PA treated ischemic stroke patients. METHODS: Patients treated with standard-dose rt-PA, not rec...
Gardado en:
| Publicado en: | Stroke |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5499711/ https://ncbi.nlm.nih.gov/pubmed/28507269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.117.016720 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|